A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China

NCT06512337 ·Status: ACTIVE_NOT_RECRUITING

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

NCT07256015 ·Status: RECRUITING

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

NCT05478499 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy

NCT00109317 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT03982394 ·Status: COMPLETED

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

NCT06143878 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan

NCT05633264 ·Status: COMPLETED

Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

NCT06258668 ·Status: RECRUITING

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

NCT03611751 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

NCT06952465 ·Status: ACTIVE_NOT_RECRUITING

A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

NCT06333860 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent

NCT00336973 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece

NCT06247319 ·Status: ACTIVE_NOT_RECRUITING

A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

NCT06095115 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

NCT04036435 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?

NCT06742333 ·Status: RECRUITING ·Phase: PHASE2

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03410992 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study in Participants With Moderate to Severe Psoriasis

NCT01474512 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

NCT03219437 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03536884 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

NCT06042920 ·Status: TERMINATED ·Phase: PHASE4

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

NCT02595970 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

NCT04908189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

NCT03218488 ·Status: ACTIVE_NOT_RECRUITING

Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis

NCT03624127 ·Status: COMPLETED ·Phase: PHASE3